SPONSORED CONTENT
TIP: When using outsourced telehealth services, be prepared to “Mind the Gap.”
Telehealth services are a great
Month: April 2023
The state of Arkansas and Arkansas 340B covered entities separately asked a federal appeals court yesterday to back a judge’s decision in December that the state’s novel 340B anti-discrimination law is not preempted by the 340B statute nor by the
…
The American Hospital Association has again blasted the drug industry’s alliance with community health centers for 340B reform, calling it “another misguided attempt by drug companies to dismantle [340B] so that they can continue to pad their billion-dollar bottom lines.”
…
SPONSORED CONTENT
Leaders of hospitals, health centers and other 340B provider institutions are busy and don’t have time in their demanding days to be involved in the detailed, day-to-day financial oversight of their 340B programs. Yet, they also can’t afford to leave valuable program dollars on the table, which fund vital and expanded patient services. Here’s a checklist of six key steps to help you optimize the financial health of your 340B program in 2023 and beyond. And if you have a 340B TPA (third-party administrator), this list can help you ask them the right questions.
340B Financial Checklist
1. Know the facts about your contracts and fees
- Be sure you know how you’re charged by your 340B TPA. Is it a flat fee per contract pharmacy, a flat fee and percentage of savings on 340B approved claims, or other?
- Are there minimum dollar amount thresholds you must meet?
U.S. Senate Health, Education, Labor, and Pensions Committee staff members reportedly have decided to exclude 340B issues from a bipartisan drug policy bill they are writing behind the scenes in order to preserve the bill’s odds of being passed next
…
A Virginia Democrat and South Dakota Republican this afternoon reintroduced bipartisan legislation in the U.S. House to protect 340B covered entities and contract pharmacies from discrimination by insurers and pharmacy benefit managers.
Reps. Abigail Spanberger (D-Va.) and Dusty Johnson (R-S.D.)
…
Drug maker Novartis told a federal appeals court in Washington, D.C. Tuesday its revised 340B contract pharmacy policy “does not impact the legal arguments at issue” in its 340B contract pharmacy case awaiting the court’s decision.
If the court disagrees,
…
Two Republican U.S. senators expressed concerns about pharmacy benefit manager encroachment on 340B covered entity savings during a Senate Finance Committee hearing on PBMs last week.
“I often hear concerns from South Dakota hospitals and health centers when it comes
…SPONSORED CONTENT
With new contract pharmacy restrictions recently announced, and more expected to come in the near future, ensuring compliance is more important than ever in the world of 340B. Here are a few takeaways from last week’s 340B Coalition winter conference in San Diego to help you and your 340B program prepare for the changes ahead.
More Restrictions
Drug manufacturers are getting increasingly restrictive regarding 340B pricing for contract pharmacy relationships. In just the past few days, Pfizer, GSK and Novartis have announced new restrictions, with GSK’s restrictions applying to all covered entities. Most of these companies are now only going to allow the use of 340B discounts in the contract pharmacy setting at the covered entity’s in-house retail pharmacy. The only exception is if the covered entity does not have an in-house outpatient pharmacy, they may designate one contract pharmacy location. In some of these instances, covered entities must also:
Maine state senators have introduced a bill to require 340B hospitals to file annual reports with detailed information on the savings they receive through 340B drug discounts, including annual 340B revenue the hospital generates minus 340B aggregate acquisition costs, and
…